CY1113332T1 - NUCLEAR ACIDS AND RELATED PROTEINS NAMED 191P4D12 (B) USEFUL IN CANCER EDUCATION AND DETECTION - Google Patents

NUCLEAR ACIDS AND RELATED PROTEINS NAMED 191P4D12 (B) USEFUL IN CANCER EDUCATION AND DETECTION

Info

Publication number
CY1113332T1
CY1113332T1 CY20121101081T CY121101081T CY1113332T1 CY 1113332 T1 CY1113332 T1 CY 1113332T1 CY 20121101081 T CY20121101081 T CY 20121101081T CY 121101081 T CY121101081 T CY 121101081T CY 1113332 T1 CY1113332 T1 CY 1113332T1
Authority
CY
Cyprus
Prior art keywords
useful
detection
related proteins
cancer
proteins named
Prior art date
Application number
CY20121101081T
Other languages
Greek (el)
Inventor
Arthur B Raitano
Pia M Challita-Eid
Aya Jakobovits
Mary Faris
Wangmao Ge
Original Assignee
Agensys, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03726484A external-priority patent/EP1576170B1/en
Application filed by Agensys, Inc. filed Critical Agensys, Inc.
Publication of CY1113332T1 publication Critical patent/CY1113332T1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Περιγράφονται νέο γονίδιο 191P4D12(b) και η κωδικευμένη πρωτεΐνη αυτού, όπου το 191P4D12(b) εμφανίζει ιστοειδική έκφραση σε φυσιολογικό ιστό ενήλικα, και εκφράζεται έκτροπα στους καρκίνους που συνοψίζονται στον πίνακα I. Κατά συνέπεια, το 191P4D12(b) παρέχει διαγνωστικό, προγνωστικό, προφυλακτικό και/ή θεραπευτικό στόχο για καρκίνο. To 191P4D12(b) γονίδιο ή θραύσμα αυτού, ή η κωδικευμένη πρωτεΐνη αυτού, ή παραλλάγματα αυτής, ή θραύσμα αυτών, μπορούν να χρησιμοποιηθούν για την πρόκληση χυμικής ή κυτταρικής ανοσοαπόκρισης-αντισώματα ή Τ κύτταρα αντιδραστικά με 191P4D12(b) μπορούν να χρησιμοποιηθούν σε ενεργή ή παθητική ανοσοποίηση.A new 191P4D12 (b) gene is described and its coding protein, where 191P4D12 (b) expresses tissue-specific expression in normal adult tissue, and is aberrant in the cancers summarized in Table I. Consequently, 191P4D12 (b) provides a diagnostic, , a prophylactic and / or therapeutic target for cancer. The 191P4D12 (b) gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, may be used to induce humoral or cellular immune response-antibodies, or 191P4D12 (b) reactive cells may be used or active or passive immunization.

CY20121101081T 2002-08-16 2012-11-13 NUCLEAR ACIDS AND RELATED PROTEINS NAMED 191P4D12 (B) USEFUL IN CANCER EDUCATION AND DETECTION CY1113332T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40430602A 2002-08-16 2002-08-16
US42329002A 2002-11-01 2002-11-01
EP03726484A EP1576170B1 (en) 2002-08-16 2003-04-23 Nucleic acids and corresponding proteins entitled 191p4d12(b) useful in treatment and detection of cancer

Publications (1)

Publication Number Publication Date
CY1113332T1 true CY1113332T1 (en) 2016-06-22

Family

ID=58448848

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121101081T CY1113332T1 (en) 2002-08-16 2012-11-13 NUCLEAR ACIDS AND RELATED PROTEINS NAMED 191P4D12 (B) USEFUL IN CANCER EDUCATION AND DETECTION

Country Status (1)

Country Link
CY (1) CY1113332T1 (en)

Similar Documents

Publication Publication Date Title
CY1113247T1 (en) NUCLEAR ACIDS WITH THE TITLE 273P4B7 AND USE IN CANCER TEST
CY1113044T1 (en) EXTERNAL ANTIGEN CELL PROTECTOR CELL EXTRACTS (PSCA) AND SUBSEQUENTS OF THESE
CY1114855T1 (en) ANTIBODIES AND PARTS COMING FROM THESE BINDING TO PROTEINS TOY STEAP-1
CY1114069T1 (en) NUCLEAR ACID AND COMPATIBLE PROTEIN WITH TITLE 161P2F10B USEFUL IN CANCER TREATMENT AND DETECTION
CY1120070T1 (en) METHOD OF THERAPEUTIC TREATMENT WITH THE USE OF ANTI-ERBB-METHYSINEOID ANTIBODY conjugates
CY1110256T1 (en) TRANSMISSIONAL CYCLE TRANSMISSIONAL LIGGIN ANTIGEN IN HUMAN PROTECTOR AND HIS USE
MXPA02000192A (en) Compositions and methods for the therapy and diagnosis of lung cancer.
CY1111591T1 (en) HYBRID EXPRESSION OF NEISSERIA PROTEINS
CY1115496T1 (en) Neurotrophic Growth Factor
EA199800946A1 (en) CONCENTRATED ANTIBODY PREPARATION
CY1107545T1 (en) METHODS FOR CAUSING DEATH OF CANCER CELLS AND TUMOR CELL
ATE267258T1 (en) VACCINES FOR THE RESPIRATORY SYNZYTIAL VIRUS WITH NUCLIC ACIDS
ATE127345T1 (en) STRESS PROTEINS AND USES THEREOF.
WO2004000094A3 (en) Predictive markers in cancer therapy
CY1117746T1 (en) Influenza hematopoietic antigens and corresponding DNA fragments
WO2001079286A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
IL181218A0 (en) Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer
ATE273388T1 (en) ALTERED HUMAN C3 PROTEINS
AU2002319501A1 (en) Materials and methods relating to improved vaccination strategies
PT1290160E (en) PELLINO HUMAN POLIPEPTIDEES
CY1109029T1 (en) NUCLEAR ACID AND CORRESPONDING PROTEIN BRAND 85P1B3 USEFUL IN Cancer Treatment and Diagnosis
CY1113332T1 (en) NUCLEAR ACIDS AND RELATED PROTEINS NAMED 191P4D12 (B) USEFUL IN CANCER EDUCATION AND DETECTION
ATE134874T1 (en) SYNOVIAL PHOSPHOLIPASES
DK1573022T3 (en) Nucleic acid and corresponding protein designated 184P1E2 suitable for the treatment and detection of cancer
NO20060637L (en) Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations